Advertisement

Refractory Congestion: When to Use Ultrafiltration?

  • Bradley A. BartEmail author
Chapter

Abstract

The symptoms of and disability related to decompensated heart failure are manifestations of congestion. Therefore, congestion is the main treatment target and diuretics are recommended as first line therapy. Refractory congestion refers to situations in which diuretics fail to produce the desired clinical effect. In these circumstances, ultrafiltration may be appropriate for the relief of congestion and improved outcomes. This chapter will review the concept of refractory congestion; describe the use of diuretics and ultrafiltration in the treatment of congestion; and review the importance of case selection when choosing to treat refractory congestion with ultrafiltration.

Keywords

Heart failure Congestion Ultrafiltration Diuretics Cardiorenal syndrome 

References

  1. 1.
    Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12(5):423–33.PubMedCrossRefGoogle Scholar
  2. 2.
    Drazner MH, Hellkamp AS, Leier CV, Shah MR, Miller LW, Russell SD, et al. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail. 2008;1(3):170–7.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Chakko S, Woska D, Martinez H, de Marchena E, Futterman L, Kessler KM, et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991;90(3):353–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261(6):884–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007;116(14):1549–54.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Zile MR, Bennett TD, St John SM, Cho YK, Adamson PB, Aaron MF, et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008;118(14):1433–41.PubMedCrossRefGoogle Scholar
  7. 7.
    Fallick C, Sobotka PA, Dunlap ME. Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation. Circ Heart Fail. 2011;4(5):669–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol. 2004;93(10):1254–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Strobeck JE, Feldschuh J, Miller WL. Heart failure outcomes with volume-guided management. JACC Heart Fail. 2018;6(11):940–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000;140(6):840–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Wattad M, Darawsha W, Solomonica A, Hijazi M, Kaplan M, Makhoul BF, et al. Interaction between worsening renal function and persistent congestion in acute decompensated heart failure. Am J Cardiol. 2015;115(7):932–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Aoki S, Okumura T, Sawamura A, Kitagawa K, Morimoto R, Sakakibara M, et al. Usefulness of the combination of in-hospital poor diuretic response and systemic congestion to predict future cardiac events in patients with acute decompensated heart failure. Am J Cardiol. 2017;119(12):2010–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, et al. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail. 2015;8(4):741–8.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Kociol RD, McNulty SE, Hernandez AF, Lee KL, Redfield MM, Tracy RP, et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail. 2013;6(2):240–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658–66.PubMedCrossRefGoogle Scholar
  16. 16.
    Darawsha W, Chirmicci S, Solomonica A, Wattad M, Kaplan M, Makhoul BF, et al. Discordance between hemoconcentration and clinical assessment of decongestion in acute heart failure. J Card Fail. 2016;22(9):680–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Mentz RJ, Kjeldsen K, Rossi GP, Voors AA, Cleland JG, Anker SD, et al. Decongestion in acute heart failure. Eur J Heart Fail. 2014;16(5):471–82.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327.PubMedGoogle Scholar
  19. 19.
    Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJ. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med. 1973;288(21):1087–90.PubMedCrossRefGoogle Scholar
  20. 20.
    Brater DC. Diuretic therapy. N Engl J Med. 1998;339(6):387–95.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Gheorghiade M. Reassessing treatment of acute heart failure syndromes: the ADHERE registry. Eur Heart J. 2005;7(Suppl):B13–9.CrossRefGoogle Scholar
  22. 22.
    Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364(9):797–805.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013;310(23):2533–43.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Massie BM, O'connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010;363(15):1419–28.PubMedCrossRefGoogle Scholar
  25. 25.
    O’Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365(1):32–43.PubMedCrossRefGoogle Scholar
  26. 26.
    Packer M, O'Connor C, McMurray JJV, Wittes J, Abraham WT, Anker SD, et al. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med. 2017;376(20):1956–64.PubMedCrossRefGoogle Scholar
  27. 27.
    Teerlink JR. RELAXin in acute heart failure-2-RELAX-AHF-2. 2017.Google Scholar
  28. 28.
    Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology. 2001;96(3–4):132–43.CrossRefGoogle Scholar
  29. 29.
    Sackner-Bernstein JD, Obeleniene R. How should diuretic-refractory, volume-overloaded heart failure patients be managed? J Invasive Cardiol. 2003;15(10):585–90.PubMedGoogle Scholar
  30. 30.
    Simpson IA, Rae AP, Simpson K, Gribben J, Boulton Jones JM, Allison ME, et al. Ultrafiltration in the management of refractory congestive heart failure. Br Heart J. 1986;55(4):344–7.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Dormans TP, Huige RM, Gerlag PG. Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide. Heart. 1996;75(4):349–51.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'connor CM, Bull DA, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367(24):2296–304.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol. 2015;12(3):184–92.PubMedCrossRefGoogle Scholar
  34. 34.
    Aronson D, Burger AJ. Diuretic response: clinical and hemodynamic predictors and relation to clinical outcome. J Card Fail. 2016;22(3):193–200.PubMedCrossRefGoogle Scholar
  35. 35.
    Brinkley DM Jr, Burpee LJ, Chaudhry SP, Smallwood JA, Lindenfeld J, Lakdawala NK, et al. Spot urine sodium as triage for effective diuretic infusion in an ambulatory heart failure unit. J Card Fail. 2018;24(6):349–54.PubMedCrossRefGoogle Scholar
  36. 36.
    Ronco C, Ricci Z, Bellomo R, Bedogni F. Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology. 2001;96(3–4):155–68.PubMedCrossRefGoogle Scholar
  37. 37.
    Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006;47(1):1–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Ali SS, Olinger CC, Sobotka PA, Dahle TG, Bunte MC, Blake D, et al. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail. 2009;15(1):1–4.PubMedCrossRefGoogle Scholar
  39. 39.
    Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49(6):675–83.PubMedCrossRefGoogle Scholar
  40. 40.
    Guazzi MD, Agostoni P, Perego B, Lauri G, Salvioni A, Giraldi F, et al. Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J. 1994;72(6):534–9.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Marenzi G, Guazzi M, Lauri G, Perego GB, Sganzerla P, Agostoni P. Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result. Cardiologia. 1994;39(11):763–72.PubMedGoogle Scholar
  42. 42.
    Bart BA, Boyle A, Bank AJ, Anand I, Olivari MT, Kraemer M, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol. 2005;46(11):2043–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Giglioli C, Landi D, Cecchi E, Chiostri M, Gensini GF, Valente S, et al. Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. Eur J Heart Fail. 2011;13(3):337–46.PubMedCrossRefGoogle Scholar
  44. 44.
    Hanna MA, Tang WH, Teo BW, O'Neill JO, Weinstein DM, Lau SM, et al. Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congest Heart Fail. 2012;18(1):54–63.PubMedCrossRefGoogle Scholar
  45. 45.
    Marenzi G, Muratori M, Cosentino ER, Rinaldi ER, Donghi V, Milazzo V, et al. Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail. 2014;20(5):378–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Grodin JL, Carter S, Bart BA, Goldsmith SR, Drazner MH, Tang WHW. Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Eur J Heart Fail. 2018;20:1148–56.PubMedCrossRefGoogle Scholar
  47. 47.
    Costanzo MR, Negoianu D, Jaski BE, Bart BA, Heywood JT, Anand IS, et al. Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC Heart Fail. 2016;4(2):95–105.PubMedCrossRefGoogle Scholar
  48. 48.
    Patarroyo M, Wehbe E, Hanna M, Taylor DO, Starling RC, Demirjian S, et al. Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol. 2012;60(19):1906–12.PubMedCrossRefGoogle Scholar
  49. 49.
    Liang KV, Hiniker AR, Williams AW, Karon BL, Greene EL, Redfield MM. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail. 2006;12(9):707–14.PubMedCrossRefGoogle Scholar
  50. 50.
    Ramos R, Salem BI, DePawlikowski MP, Tariq M, Haikal M, Pohlman T, et al. Outcome predictors of ultrafiltration in patients with refractory congestive heart failure and renal failure. Angiology. 1996;47(5):447–54.PubMedCrossRefGoogle Scholar
  51. 51.
    Siddiqui WJ, Kohut AR, Hasni SF, Goldman JM, Silverman B, Kelepouris E, et al. Readmission rate after ultrafiltration in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev. 2017;22(6):685–98.PubMedCrossRefGoogle Scholar
  52. 52.
    Costanzo MR, Ronco C, Abraham WT, Agostoni P, Barasch J, Fonarow GC, et al. Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research. J Am Coll Cardiol. 2017;69(19):2428–45.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Hennepin County Medical CenterMinneapolisUSA
  2. 2.University of MinnesotaMinneapolisUSA

Personalised recommendations